| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |